查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197391

喉鏡市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Laryngoscope Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，喉鏡市場預計將以 9.4% 的複合年增長率增長。

COVID-19 大流行最初對喉鏡市場的影響不大。 旨在減緩 COVID-19 傳播的嚴格封鎖和政府限制導致非緊急病例的就診人數減少。 然而，COVID-19 主要影響呼吸系統，導致對包括喉鏡在內的呼吸和血管通路產品的直接需求。 此外，一些指南和評論，包括來自英國困難氣道協會、麻醉師協會、重症監護協會和皇家麻醉學院的指南和評論，建議對需要進行喉鏡檢查的疑似或確診 COVID-19 患者進行直接喉鏡檢查插管。我們推薦通過視頻喉鏡進行氣管插管。 此外，歐洲復甦委員會 COVID-19 成人高級生命支持指南也在其指南中提到了視頻喉鏡建議。 這些建議增加了對喉鏡的需求。 此外，一些國際組織支持醫療機構加強對需要插管的重症 COVID-19 患者的臨床管理反應。 例如，2021 年 1 月，泛美衛生組織和世衛組織向 Karl Heusner 紀念醫院管理局 (KHMHA) 捐贈了一個視頻喉鏡。 因此，COVID-19 的爆發對其前身的市場增長產生了負面影響，但由於全球喉鏡的使用增加，該市場獲得了巨大的吸引力。

此外，喉部疾病患病率的增加和喉鏡在氣道管理中的使用增加是推動所研究市場增長的主要因素。 人口中吸煙者的高比例和喉癌發病率的增加也導致了喉部疾病患病率的上升。 預計這些因素將增加對喉鏡的需求，並有助於市場的增長。

常見的喉部疾病包括喉炎、聲帶結節、聲帶息肉、Reinke水腫和會厭囊腫。 也已經證實，喉部疾病的患病率在男性中較高。 此外，美國癌症協會估計，2022 年美國將有大約 12,470 例新發喉癌病例（9,820 名男性，2,650 名女性）。 喉鏡檢查對聲帶和喉嚨附近區域進行活檢，以幫助檢測癌症。 因此，喉部疾病患病率的增加勢必會加速全球喉鏡市場的發展，並有望在未來這樣做，從而在預測期內推動所研究市場的增長。

此外，市場主要參與者的新產品發布和戰略活動對所研究市場的增長產生了積極影響。 例如，2021 年 5 月，Penlon Limited 推出了用於其 MRI 套件的全新改進型喉鏡刀片和手柄系列。 因此，由於產品發布和戰略活動，預計所研究的市場在預測期內將顯著增長。

因此，由於上述因素，該市場有望在預測期內增長。 然而，與使用喉鏡相關的傷害可能會阻礙市場增長。

喉鏡市場趨勢

視頻喉鏡預計在預測期內增長

視頻喉鏡被認為是喉鏡的革命性進步，因為它們可以讓您看到無法直接看到的區域。 與傳統喉鏡相比，視頻喉鏡氣管插管越來越多地被採用。 與光纖喉鏡相比，視頻喉鏡還具有對喉鏡醫師要求較少專業知識的優勢。 它還為遠程監控創造了機會，這可能對資源匱乏的醫院和院前緊急氣道管理有用。 因此，由於視頻喉鏡的優勢，醫生對這些產品的需求可能會增加，最終推動這一細分市場的增長。

此外，根據 2022 年發表的 Cochrane 協作組織研究，與傳統的 Macintosh 喉鏡相比，視頻喉鏡可能會減少插管失敗的次數。 所有視頻喉鏡還可以增加首次嘗試插管成功的機會，並可以提高聲帶的可見度。 因此，視頻喉鏡提供的各種優勢為該細分市場的未來增長創造了機會。

此外，市場主要參與者不斷推出的產品對該細分市場的增長產生了積極影響。 例如，2022 年 4 月，全球領先的半導體解決方案開發商 OmniVision 宣布了一項新的喉鏡參考設計，其中包括用於一次性視頻喉鏡的 OmniVision 產品系列。 這有望幫助醫療設備原始設備製造商縮短喉鏡開發的上市時間。

因此，由於上述因素，預計視頻喉鏡部分在預測期內將出現顯著增長。

北美有望主導喉鏡市場

由於技術先進的產品隨時可用、醫療支出高、醫療基礎設施發達以及該地區喉部疾病的高患病率，預計北美將主導該市場。 例如，估計 2021 年加拿大將有 7,400 人被診斷出患有頭頸癌。 此外，在美國越來越多地使用視頻喉鏡以獲得有效結果是促進北美研究市場增長的關鍵因素之一。

主要產品發布、市場參與者高度集中以及製造商在美國的存在是推動該國喉鏡市場增長的一些因素。 例如，2022年5月，Ambu在歐美推出了用於內窺鏡的顯示單元“Ambu aView 2 Advance”。 Ambu aView 2 Advance 與 Ambu 支氣管鏡、鼻喉鏡和膀胱鏡配合使用，可選擇將記錄的數據傳輸到醫院的電子病歷。 此類產品的持續推出有望推動該地區的市場增長。

因此，由於上述因素，北美地區的市場有望增長。

喉鏡市場競爭對手分析

由於多家公司在全球和區域運營，因此喉鏡市場是一個分散的市場。 競爭格局包括 Medtronic、Baxter（Hill-Rom）、Olympus Corporation、Nihon Kohden、Teleflex、Ambu AS、BPL Group（Penron）、Claras Medical LLC、KARL STORZ、FlexiCare Medical 等。包括對幾個知名國際公司的分析和區域公司。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 喉部疾病的增加和喉鏡在氣道管理中的使用增加
    • 技術先進的產品介紹
  • 市場製約因素
    • 與使用喉鏡有關的傷害
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（金額基礎：百萬美元）

  • 按類型
    • 光纖喉鏡
    • 電子喉鏡
  • 按組件
    • 喉鏡刀片
    • 處理
    • 耗材/配件
  • 使用感受
    • 一次性的
    • 可重複使用
  • 最終用戶
    • 醫院
    • 診所
    • 門診手術中心
    • 其他最終用戶
  • 按地區細分
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Medtronic
    • Baxter（Hillrom）
    • Olympus Corporation
    • Nihon Kohden
    • Teleflex
    • Ambu A/S
    • BPL Group（Penlon Ltd）
    • Clarus Medical LLC
    • Karl Storz
    • Flexicare Medical Ltd

第7章 市場機會與今後動向

簡介目錄
Product Code: 92775

The Laryngoscope Market is expected to register a CAGR of 9.4% over the forecast period.

The COVID-19 pandemic initially had a moderate impact on the laryngoscope market. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decline in the number of patients visiting for non-emergency cases. However, COVID-19 primarily affected the respiratory system, leading to an immediate demand for respiratory and vascular access products, including laryngoscopes. Furthermore, several guidelines and reviews, including those from the UK Difficult Airway Society, the Association of Anaesthetists, the Intensive Care Society, and the Royal College of Anaesthetists, have recommended tracheal intubation with a video laryngoscope in preference to a direct laryngoscope for patients with suspected or confirmed COVID-19 who require intubation. Furthermore, the European Resuscitation Council COVID-19 Guidelines for Advanced Life Support in Adults also mentioned in their guidelines recommending video laryngoscopes. These recommendations led to a higher demand for laryngoscopes. Moreover, several international bodies supported healthcare facilities in strengthening the clinical management response for caring for people with severe COVID-19 infection who need intubation. For instance, in January 2021, the PAHO and WHO donated a video laryngoscope to the Karl Heusner Memorial Hospital Authority (KHMHA). Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the market gained significant traction due to the increased use of laryngoscopes globally.

Further, the increasing prevalence of laryngeal disease and the rise in the use of laryngoscopes in airway management are among the major factors driving the growth of the market studied. In addition, the high rate of smokers among the population and the increasing incidences of laryngeal cancer are also leading to a higher prevalence of the laryngeal disease. Such factors will likely boost the demand for laryngoscopy, thereby contributing to the market's growth.

Some common laryngeal diseases include laryngitis, vocal nodules, vocal polyps, Reinke's edema, and epiglottic cyst, among others. In addition, it has been observed that the prevalence of laryngeal disease is higher in males. Moreover, the American Cancer Society estimates that in 2022, there will be about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) in the United States. Laryngoscopy takes biopsy samples of the vocal cords or nearby parts of the throat to detect cancer further. Thus, the increasing prevalence of the laryngeal disease is poised to accelerate the laryngoscope market globally and is expected to increase in the future, thereby driving the growth of the market studied over the forecast period.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the market studied. For instance, in May 2021, Penlon Limited launched a new and improved range of laryngoscope blades and handles for use in the MRI suite. Thus, due to the product launches and strategic activities, the market studied is expected to grow significantly over the forecast period.

Therefore, owing to the abovementioned factors, it is anticipated that the market studied will witness growth over the forecast period. However, the injuries associated with the use of laryngoscopes are likely to impede the market's growth.

Laryngoscope Market Trends

Video Laryngoscope Segment is Expected to Witness Growth Over the Forecast Period

Video laryngoscope is considered a very innovative advancement in laryngoscopy as it offers various advantages to the operator by allowing him to see what is not within his direct line of sight. Tracheal intubation by video laryngoscope is increasingly being adopted compared to a conventional laryngoscope. In addition, video laryngoscopes also benefit from laryngoscopists requiring less expertise than fiber optic laryngoscopes. Moreover, it also creates an opportunity for remote supervision, which may be helpful for under-resourced hospitals and during prehospital emergency airway management. Hence, owing to the advantages of video laryngoscopes, the demand for these products is likely to increase among physicians, ultimately driving the growth of this market segment.

In addition, according to the Cochrane Collaboration study published in 2022, video laryngoscope probably reduces the number of failed intubations compared to the traditional Macintosh laryngoscope. All video laryngoscopes may also increase the chances of being successfully intubated on the first attempt and improve the view of the vocal cords. Thus, the various benefits that video laryngoscopes offer create opportunities for future growth of the segment.

Furthermore, continuous product launches by major players in the market are positively affecting the segment's growth. For instance, in April 2022, OmniVision, a leading global developer of semiconductor solutions, launched a new laryngoscope reference design that included a range of OmniVision products for single-use video laryngoscopes. This is anticipated to help medical device OEMs speed time-to-market in developing laryngoscopes.

Therefore, the video laryngoscope segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America is Expected to Dominate the Laryngoscope Market

North America is expected to dominate the market owing to factors such as the easy availability of technologically advanced products, high medical spending, well-developed medical infrastructure, and the high prevalence of laryngeal disease in the region. For instance, an estimated 7,400 people in Canada were diagnosed with head and neck cancers in 2021. Moreover, an increase in the usage of video laryngoscopes for effective results in the United States is among the key factors contributing to the growth of the market studied in North America.

Key product launches, the high concentration of market players, and the manufacturer's presence in the United States are some of the factors driving the growth of the laryngoscope market in the country. For instance, in May 2022, Ambu launched its Ambu aView 2 Advance Display Unit for use with endoscopes in Europe and the United States. The Ambu aView 2 Advance can be used with Ambu's bronchoscope, rhinolaryngoscope, or cystoscope while offering the option to transfer recorded data to the hospital's electronic health records. These continuous product launches in the region are anticipated to drive the growth of the market in the country.

Therefore, owing to the aforementioned factors, the market's growth is anticipated in the North American region.

Laryngoscope Market Competitor Analysis

The Laryngoscope market is fragmented due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well-known, including Medtronic, Baxter (Hillrom), Olympus Corporation, Nihon Kohden, Teleflex, Ambu AS, BPL Group (Penlon Ltd), Clarus Medical LLC, Karl Storz, Flexicare Medical Ltd, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Laryngeal Disease and Rise in the Use of Laryngoscopes in Airway Management
    • 4.2.2 Introduction of Technologically Advanced Products
  • 4.3 Market Restraints
    • 4.3.1 Injuries Associated with the Use of Laryngoscopes
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value in USD million)

  • 5.1 By Type
    • 5.1.1 Fiber Optic Laryngoscope
    • 5.1.2 Video Laryngoscope
  • 5.2 By Component
    • 5.2.1 Laryngoscope Blades
    • 5.2.2 Handle
    • 5.2.3 Consumables and Accessories
  • 5.3 By Usability
    • 5.3.1 Disposable
    • 5.3.2 Reusable
  • 5.4 By End-User
    • 5.4.1 Hospital
    • 5.4.2 Clinics
    • 5.4.3 Ambulatory Surgical Centers
    • 5.4.4 Other End-Users
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic
    • 6.1.2 Baxter (Hillrom)
    • 6.1.3 Olympus Corporation
    • 6.1.4 Nihon Kohden
    • 6.1.5 Teleflex
    • 6.1.6 Ambu A/S
    • 6.1.7 BPL Group (Penlon Ltd)
    • 6.1.8 Clarus Medical LLC
    • 6.1.9 Karl Storz
    • 6.1.10 Flexicare Medical Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS